OPK

OPKO Health, Inc.

33
Fundamentals17/ 100
Valuation50/ 100
Upside potential56/ 100
Risk potential26/ 100

OPK lost money over the past year, so it has no meaningful PE right now.

OPK Fundamentals

MetricStatus
Weak
Under pressure
Weak
Strong

OPK's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.

OPK PE Valuation

OPK has no meaningful PE right now: it lost money over the past year.

OPK Forward outlook

MetricOutlook
--
Losses steady
Strong decline
Strongly weakening
Limited
Low

Analysts expect OPK's revenue and profitability to decline, with its earnings holding steady. However, they disagree widely on these estimates.

OPK Risk to reward

ScenarioChangePrice
Upside+34%$2.23
Downside-26%$1.24

Calculated from the latest close: $1.67 on Nov 12.

OPK's one-year upside scenario is somewhat larger than its downside: +34% against −26%.

OPK Earnings Per Share

Q4 2023: $-0.25Q1 2024: $-0.35Q2 2024: $-0.33Q3 2024: $-0.19Q4 2024: $-0.09Q1 2025: $-0.07Q2 2025: $-0.25Q3 2025: $-0.25Q4 2025: $-0.30Q1 2026: $-0.27Q2 2026: $-0.09Q3 2026: $-0.19
Q4 2023: $-0.25Q1 2024: $-0.35Q2 2024: $-0.33Q3 2024: $-0.19Q4 2024: $-0.09Q1 2025: $-0.07Q2 2025: $-0.25Q3 2025: $-0.25Q4 2025: $-0.30Q1 2026: $-0.27Q2 2026: $-0.09Q3 2026: $-0.19
QuarterTTM EPSYoY
Q3 2026-$0.19+$0.06
Q2 2026-$0.09+$0.16
Q1 2026-$0.27-$0.20
Q4 2025-$0.30-$0.21
Q3 2025-$0.25-$0.06
Q2 2025-$0.25+$0.08
Q1 2025-$0.07+$0.28
Q4 2024-$0.09+$0.16

OPK is still losing money, but far less than before: $0.19 per share over the past year, against $0.53 at its worst in late 2019.

OPK Quarterly Revenue

Q4 2023: $182MQ1 2024: $174MQ2 2024: $182MQ3 2024: $174MQ4 2024: $184MQ1 2025: $150MQ2 2025: $157MQ3 2025: $152MQ4 2025: $148MQ1 2026: $124MQ2 2026: $164MQ3 2026: $65M
Q4 2023: $182MQ1 2024: $174MQ2 2024: $182MQ3 2024: $174MQ4 2024: $184MQ1 2025: $150MQ2 2025: $157MQ3 2025: $152MQ4 2025: $148MQ1 2026: $124MQ2 2026: $164MQ3 2026: $65M
QuarterRevenueYoY
Q3 2026$65.4M-57%
Q2 2026$163.6M+4.3%
Q1 2026$124.2M-17%
Q4 2025$148.5M-19%
Q3 2025$151.7M-13%
Q2 2025$156.8M-14%
Q1 2025$150M-14%
Q4 2024$183.6M+1%

OPK's revenue has slid since its 2021 peak: $65M last quarter, down 57% from the same quarter a year ago.

OPK Free Cash Flow

Q4 2023: −$41MQ1 2024: −$40MQ2 2024: −$34MQ3 2024: --Q4 2024: --Q1 2025: −$38MQ2 2025: −$87MQ3 2025: −$38MQ4 2025: −$29MQ1 2026: −$21MQ2 2026: −$47MQ3 2026: −$39M
Q4 2023: −$41MQ1 2024: −$40MQ2 2024: −$34MQ3 2024: --Q4 2024: --Q1 2025: −$38MQ2 2025: −$87MQ3 2025: −$38MQ4 2025: −$29MQ1 2026: −$21MQ2 2026: −$47MQ3 2026: −$39M
QuarterFree cash flowYoY
Q3 2026-$39.1M-$1.3M
Q2 2026-$46.5M+$40.2M
Q1 2026-$21.1M+$16.6M
Q2 2025-$86.7M-$53.1M
Q1 2025-$37.7M+$2.3M
Q2 2024-$33.7M-$27.3M
Q1 2024-$40M-$14.3M
Q4 2023-$41.3M-$3.4M

OPK has burned cash in most quarters: −$135M over the past year, against −$196M the year before.

OPK Total Shares

Q4 2023: 752MQ1 2024: 707MQ2 2024: 697MQ3 2024: 998MQ4 2024: 694MQ1 2025: 672MQ2 2025: 788MQ3 2025: 780MQ4 2025: 751MQ1 2026: 759MQ2 2026: 755MQ3 2026: 746M
Q4 2023: 752MQ1 2024: 707MQ2 2024: 697MQ3 2024: 998MQ4 2024: 694MQ1 2025: 672MQ2 2025: 788MQ3 2025: 780MQ4 2025: 751MQ1 2026: 759MQ2 2026: 755MQ3 2026: 746M
PeriodChange %Net change
Quarterly-1.2%-8.8M shares
1 year-4.3%-33.4M shares
3 years-0.7%-5M shares
5 years+15%+94.6M shares
Available history+25%+151M shares

OPK has 746M diluted shares, down 4.3% from a year ago, with $42M in buybacks over the past year.

OPK Net Leverage

Q2 2026: -7.2x
Q2 2026: -7.2x
QuarterNet LeverageStatus
Q2 2026-7.2xNet Cash
Q4 20210.7xVery low
Q3 2021-0.7xNet Cash
Q2 2021-0.3xNet Cash
Q1 2021-0.4xNet Cash
Q4 20201.3xHealthy

OPK has more cash than debt.

OPK Weekly Momentum

MetricValueStatus
RSI58.9Neutral
Stochastic74.7Neutral

OPK's weekly RSI is 59 (neutral) and its Stochastic is 75 (neutral).

OPK PE vs Healthcare Sector

MetricOPKSector medianRelative
PEN/A26x—

OPK has no meaningful PE right now: it lost money over the past year.

OPK Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$1.604.4% above
20 week MA$1.5011% above
50 week MA$1.3623% above
100 week MA$1.4019% above
200 week MA$1.4218% above

OPK has climbed back above all five of its weekly moving averages, and it's now 18% above its 200-week average.

OPK Yearly ROI

YearStart priceEnd priceROI
2020$1.50$4.23+182%
2021$4.23$4.77+13%
2022$4.77$1.14-76%
2023$1.14$1.51+32%
2024$1.51$1.48-2%
2025$1.48$1.29-13%
2026 YTD$1.29$1.67+29%

OPK's yearly returns have swung widely, from +182% in 2020 to −76% in 2022. It's up 29% so far in 2026.

Give your agent the market.

Get API key